<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 8, 2001
----------------
THE MED-DESIGN CORPORATION
---------------------------
(Exact Name of Registrant Specified in Charter)
Delaware 0-25852 77-0404919
---------------- --------------------- ------------------
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification No.)
Incorporation)
2810 Bunsen Avenue
Ventura, California 93003
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (805) 339-0375
--------------
--------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Letter to investors, healthcare workers and other
professionals to be posted on The Med-Design
Corporation (the "Company") website.
Item 9. Regulation FD Disclosure.
Following the filing of this Form 8-K, the Company will post
on its website a letter to investors, healthcare workers and other professionals
(the "Letter"). The Letter is filed as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
THE MED-DESIGN CORPORATION
(Registrant)
By /s/ James Donegan
-------------------------------------
James Donegan
Chief Executive Officer
Dated: January 8, 2001
<PAGE>
Exhibit Index
Exhibit
99.1 Letter to investors, healthcare workers and other
professionals to be posted on the Company's website.
